English

Royalty Pharma $RPRX July to September 2021 Results

スポンサーリンク
English

Royalty Pharma (ticker symbol: RPRX) announced its financial results for the period July to September 2021 on November 10, 2021.

Financial Results for July to September 2021

The equivalent of sales for a normal company is adjusted cash receipts (ACR).

The ACR was $587 million, up 24% from the same period last year. In the same period last year, it was $472 million.

The equivalent of ordinary corporate profits is non-GAAP adjusted cash flow (ACF).

ACF was $441 million, up 12% from the same period last year. In the same period last year, it was $394 million. This translates to 73¢ per share. In the same period last year, it was 65¢ per share.

Operating cash flow was $470 million, down 8% from the same period last year.

タイトルとURLをコピーしました